Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenomedullin | 8 | 2025 | 78 | 1.500 |
Why?
|
| Calcitonin Gene-Related Peptide | 6 | 2021 | 85 | 1.430 |
Why?
|
| Peptide Hormones | 7 | 2016 | 69 | 1.410 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2021 | 177 | 1.160 |
Why?
|
| Placenta | 3 | 2016 | 511 | 0.790 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2021 | 226 | 0.730 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2021 | 40 | 0.690 |
Why?
|
| Vesicular Transport Proteins | 1 | 2021 | 137 | 0.650 |
Why?
|
| Omentum | 2 | 2016 | 41 | 0.610 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2016 | 86 | 0.610 |
Why?
|
| Vasodilation | 2 | 2016 | 173 | 0.580 |
Why?
|
| Arteries | 2 | 2016 | 194 | 0.570 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 2 | 2016 | 9 | 0.510 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 125 | 0.480 |
Why?
|
| Mucin-1 | 1 | 2015 | 34 | 0.470 |
Why?
|
| Amniotic Fluid | 1 | 2016 | 147 | 0.460 |
Why?
|
| Estrous Cycle | 1 | 2014 | 35 | 0.440 |
Why?
|
| Abortion, Spontaneous | 1 | 2015 | 83 | 0.440 |
Why?
|
| Decidua | 1 | 2015 | 135 | 0.440 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 89 | 0.430 |
Why?
|
| Nitric Oxide | 2 | 2016 | 461 | 0.430 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 219 | 0.430 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 202 | 0.430 |
Why?
|
| Ovulation | 1 | 2014 | 107 | 0.420 |
Why?
|
| Neuropeptides | 1 | 2014 | 113 | 0.420 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 252 | 0.420 |
Why?
|
| Embryo Implantation | 1 | 2015 | 223 | 0.410 |
Why?
|
| Peptide Fragments | 1 | 2016 | 756 | 0.370 |
Why?
|
| Ovary | 1 | 2014 | 358 | 0.370 |
Why?
|
| Pregnancy | 8 | 2021 | 7373 | 0.310 |
Why?
|
| Calcitonin Receptor-Like Protein | 3 | 2016 | 21 | 0.280 |
Why?
|
| Trophoblasts | 2 | 2016 | 113 | 0.230 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2025 | 211 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 452 | 0.170 |
Why?
|
| Multigene Family | 1 | 2021 | 289 | 0.160 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 2 | 2016 | 9 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 132 | 0.140 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 107 | 0.130 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 1 | 2016 | 10 | 0.130 |
Why?
|
| Uterine Artery | 1 | 2016 | 25 | 0.130 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2016 | 30 | 0.130 |
Why?
|
| Bradykinin | 1 | 2016 | 45 | 0.120 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 163 | 0.120 |
Why?
|
| Female | 9 | 2021 | 68330 | 0.120 |
Why?
|
| Chorionic Villi | 1 | 2015 | 22 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 188 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 51 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 118 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 822 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 2015 | 222 | 0.110 |
Why?
|
| Corpus Luteum | 1 | 2014 | 25 | 0.110 |
Why?
|
| Insulin | 1 | 2019 | 1128 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 637 | 0.110 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2014 | 20 | 0.110 |
Why?
|
| Hypoxia | 1 | 2015 | 243 | 0.100 |
Why?
|
| Granulosa Cells | 1 | 2014 | 139 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1126 | 0.100 |
Why?
|
| Fetal Development | 1 | 2014 | 126 | 0.090 |
Why?
|
| Rats | 2 | 2016 | 3390 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2893 | 0.080 |
Why?
|
| Humans | 8 | 2025 | 126753 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3314 | 0.070 |
Why?
|
| Animals | 4 | 2025 | 33051 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 534 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2304 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2025 | 134 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2025 | 1015 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2310 | 0.040 |
Why?
|
| Adult | 2 | 2019 | 30410 | 0.040 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2019 | 16 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 199 | 0.040 |
Why?
|
| Lung | 1 | 2025 | 1516 | 0.030 |
Why?
|
| Receptor Activity-Modifying Proteins | 1 | 2015 | 16 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 538 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 675 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4429 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 1082 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2560 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 1536 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 459 | 0.020 |
Why?
|
| Uterus | 1 | 2016 | 532 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1595 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 17596 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 4472 | 0.010 |
Why?
|